Emergent BioSolutions Inc.
10/04/2024 | Press release | Distributed by Public on 10/04/2024 05:30
Management Change/Compensation Form 8 K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(e) On October 2, 2024, the Compensation Committee of the Board of Directors of Emergent BioSolutions Inc. (the "Company"), approved a special one-time discretionary equity award to be granted to Richard S. Lindahl, the Company's Executive Vice President, Chief Financial Officer and Treasurer of 15,000 restricted stock units, which will have a grant date of October 15, 2024 and will vest on the first anniversary of the date of grant (the "Award"). The Award is subject to Mr. Lindahl's continued employment with the Company through the applicable vesting date, the terms and conditions of the Company's Amended and Restated Stock Incentive Plan, Global Restricted Stock Unit Award Agreement, and Second Amended and Restated Senior Management Severance Plan. This Award is in recognition of Mr. Lindahl's substantial contributions in executing recent strategic initiatives.